Biomaterials and Biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering
Description
Advanced drug delivery systems are having an enormous impact on human health. new drug delivery technologies including nanoparticles and nanotechnology are now being studied for use in treating cancer. Approaches for synthesizing new biomaterials, which can be used in fighting brain cancer and new approaches for engineering tissues are being developed that may someday help in various diseases. Robert Samuel Langer, Jr. is an American chemical engineer, scientist, entrepreneur, inventor and the David H. Koch Institute Professor at the Massachusetts Institute of Technology. He is a widely recognized and cited researcher in biotechnology, especially in the fields of drug delivery systems and tissue engineering. His publications have been cited approximately 220,000 times and his h-index is 233.
Dr Tadhg Kennedy, Associate Professor in the Department of Chemical Sciences, Faculty of Science and Engineering, Bernal Institute – winner of the Early Career Researcher – Consolidator Award 2023. Since 2016 Tadhg has established a well-funded group, securing more than €5 million in funding....
Published 01/31/24
Up to 45% of us will get knee osteoarthritis in our lifetime, yet it is often not prioritised, people with joint disease are being under-served in terms of delivery of evidence-based rehabilitation in the form of exercise and education, particularly for hip and knee osteoarthritis. Evidence...
Published 01/31/24